XML 26 R20.htm IDEA: XBRL DOCUMENT
v3.25.1

Non-controlling Interest | 3 Months Ended
--- | ---
Mar. 31, 2025
Noncontrolling Interest [Abstract] |
Non-controlling Interest | Note M – Non-controlling Interest Non-controlling interest recorded in our condensed consolidated financial statements as of March 31, 2025 and December 31, 2024, relates to the following approximate interests in certain consolidated subsidiaries, which we do not own.
|  | March 31, 2025 |  |  | December 31, 2024 |
MiNK Therapeutics, Inc. |  |  | 45 | % |  |  | 45 | %
SaponiQx, Inc. |  |  | 30 | % |  |  | 30 | %
Changes in non-controlling interest for the periods ended March 31, 2025 and December 31, 2024, were as follows (in thousands):
|  | March 31, 2025 |  |  | December 31, 2024 |
Beginning balance |  | $ | 19,956 |  |  | $ | 11,949 |
Net loss attributable to non-controlling interest |  |  | (1,104 | ) |  |  | (5,059 | )
Other items: |  |  |  |  |  |
Sale of subsidiary shares in private placement |  |  | — |  |  |  | 10,234 |
Issuance of subsidiary shares for employee stock purchase plan and exercise of options |  |  | 1 |  |  |  | 20 |
Subsidiary share-based compensation |  |  | 597 |  |  |  | 2,812 |
Total other items |  |  | 598 |  |  |  | 13,066 |
Ending balance |  | $ | 19,450 |  |  | $ | 19,956 |
Sale of subsidiary shares in private placement In May 2024, MiNK entered into a Stock Purchase Agreement with a certain investor (the “Purchaser”), pursuant to which MiNK issued and sold an aggregate of 464,000 shares of its Common Stock (the “MiNK Common Shares”), at a purchase price of $12.50 per share. The aggregate purchase price paid by the Purchaser for the MiNK Common Shares was approximately $5.8 million, net of offering expenses.

X
- Definition The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 810 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/810/tableOfContent + Details
Name: | us-gaap_MinorityInterestDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NoncontrollingInterestAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration